IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
October 06 2022 - 4:05PM
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today
announced the appointment of Hilda Scharen-Guivel to the Iradimed
Board of Directors, effective October 4, 2022. Following the
appointment of Ms. Scharen-Guivel, the Board will comprise five
directors, three of whom are independent.
“We are pleased to welcome Hilda Scharen-Guivel to
the Iradimed Board,” said Roger Susi, President and Chief Executive
Officer of the Company. “Hilda’s deep experience in regulatory
oversight in the medical device industry will be invaluable to
Iradimed as we develop new products and grow our business to better
serve patients.”
Ms. Scharen-Guivel, 52, is a recently retired Program Director
of the Food and Drug Administration Center of Devices and
Radiological Health, where she most recently led and implemented
the new Medical Device Development Tools program. Her career spans
over 25 years within multiple federal agencies, including the U.S.
Food and Drug Administration, the Department of Health and Human
Services, and the National Institutes of Health. She served on
active duty as a Captain of the United States Public Health Service
for 27 years. Ms. Scharen-Guivel received a Bachelor of Science in
Biomedical Engineering and a Master’s Degree in Engineering from
the Catholic University of America.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in developing innovative
Magnetic Resonance Imaging (“MRI”) compatible medical devices. We
develop, manufacture, market, and distribute MRI-compatible medical
devices and accessories, disposables, and services relating to
them.
We are the only known provider of a non-magnetic intravenous
(“IV”) infusion pump system that is specifically designed to be
safe for use during MRI procedures. We were the first to develop an
infusion delivery system that largely eliminates many of the
dangers and problems present during MRI procedures. Standard
infusion pumps contain magnetic and electronic components which can
create radio frequency interference and are dangerous to operate in
the presence of the powerful magnet that drives an MRI system. Our
patented MRidium® MRI-compatible IV infusion pump system has been
designed with a non-magnetic ultrasonic motor, uniquely designed
non-ferrous parts, and other special features to deliver anesthesia
safely and predictably and other IV fluids during various MRI
procedures. Our pump solution provides a seamless approach that
enables accurate, safe, and dependable fluid delivery before,
during, and after an MRI scan, which is important to critically ill
patients who cannot be removed from their vital medications and
children and infants who must generally be sedated to remain
immobile during an MRI scan.
Our 3880 MRI-compatible patient vital signs monitoring system
has been designed with non-magnetic components and other special
features to monitor a patient’s vital signs safely and accurately
during various MRI procedures. The IRADIMED 3880 system operates
dependably in magnetic fields up to 30,000 gauss, which means it
can operate virtually anywhere in the MRI scanner room. The
IRADIMED 3880 has a compact, lightweight design allowing it to
travel with the patient from the critical care unit to the MRI and
back, resulting in increased patient safety through uninterrupted
vital signs monitoring and decreasing the amount of time critically
ill patients are away from critical care units. The features of the
IRADIMED 3880 include: wireless ECG with dynamic gradient
filtering; wireless SpO2 using Masimo® algorithms; non-magnetic
respiratory CO2; invasive and non-invasive blood pressure; patient
temperature, and optional advanced multi-gas anesthetic agent unit
featuring continuous Minimum Alveolar Concentration measurements.
The IRADIMED 3880 MRI compatible patient vital signs monitoring
system has an easy-to-use design and allows for the effective
communication of patient vital signs information to clinicians.
For more information, please visit www.iradimed.com.
Media Contact:
John “Jack” Glenn
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Nov 2023 to Nov 2024